A phase II study of weekly gemcitabine and vinorelbine in children with recurrent or refractory Hodgkin's disease.
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2013
At a glance
- Drugs Gemcitabine (Primary) ; Vinorelbine (Primary) ; Filgrastim
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 25 Jul 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 28 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2007 Status changed from suspended to in progress.